NYSEArca - Delayed Quote USD

Direxion Daily S&P Biotech Bull 3X Shares (LABU)

111.79 -5.60 (-4.77%)
At close: May 17 at 4:00 PM EDT
112.05 +0.26 (+0.23%)
After hours: May 17 at 7:59 PM EDT
Loading Chart for LABU
DELL
  • Previous Close 117.39
  • Open 118.06
  • Bid 111.91 x 1300
  • Ask 112.50 x 800
  • Day's Range 110.78 - 119.04
  • 52 Week Range 48.40 - 176.99
  • Volume 1,316,435
  • Avg. Volume 2,537,184
  • Net Assets 949.09M
  • NAV 111.64
  • PE Ratio (TTM) --
  • Yield 0.64%
  • YTD Daily Total Return -8.23%
  • Beta (5Y Monthly) 2.59
  • Expense Ratio (net) 0.96%

The fund, under normal circumstances, invests at least 80% of its net assets in financial instruments, such as swap agreements, securities of the index, and ETFs that track the index, that, in combination, provide 3X daily leveraged exposure to the index, consistent with the fund's investment objective. The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards ("GICS"). The fund is non-diversified.

Direxion Funds

Fund Family

Trading--Leveraged Equity

Fund Category

949.09M

Net Assets

2015-05-28

Inception Date

Performance Overview: LABU

Trailing returns as of 5/17/2024. Category is Trading--Leveraged Equity.

YTD Return

LABU
8.23%
Category
--
 

1-Year Return

LABU
15.66%
Category
--
 

3-Year Return

LABU
54.89%
Category
--
 

People Also Watch

Holdings: LABU

Top 6 Holdings (5.24% of Total Assets)

SymbolCompany% Assets
ALPN
Alpine Immune Sciences, Inc. 1.20%
RVMD
Revolution Medicines, Inc. 0.84%
IBRX
ImmunityBio, Inc. 0.83%
VKTX
Viking Therapeutics, Inc. 0.81%
MRNA
Moderna, Inc. 0.78%
EXEL
Exelixis, Inc. 0.77%

Sector Weightings

SectorLABU
Healthcare   100.00%
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Recent News: LABU

Research Reports: LABU

Related Tickers